COLLEGIUM PHARMACEUTICAL, INC (COLL) Current Federal Tax Expense (Benefit) USD 2022 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Collegium Pharmaceutical, Inc annual/quarterly Current Federal Tax Expense (Benefit) history and growth rate from 2022 to 2023.
  • Collegium Pharmaceutical, Inc Current Federal Tax Expense (Benefit) for the quarter ending March 31, 2021 was $0.000.
  • Collegium Pharmaceutical, Inc annual Current Federal Tax Expense (Benefit) for 2023 was $21.5 M, a 12854% increase from 2022.
Current Federal Tax Expense (Benefit), Annual (USD)
Current Federal Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $21.5 M +$21.3 M +12854% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 $166 K Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.